SHOW NOTES [ 00:00 ] Introduction [ 02:00 ] Living With Obesity & the Moment of Change [ 06:00 ] Keto, CGMs, and Hitting a Wall [ 10:00 ] The Heart Scare & Spiritual Wake-Up Call [ 15:00 ] Alcohol, Healing & Weight Re-Ignition [ 19:00 ] What Mounjaro Taught Him [ 23:00 ] GLP-1 Myths & Misunderstandings [ 27:00 ] Heart Failure Story & Faith [ 31:00 ] The Spiritual Side of Weight Release [ 37:00 ] Emotional Regulation & Nervous System Reset [ 43:00 ] Breaking News: Gene Therapy and Revita/Rejuva programs from Fractal Health [ 48:00 ] Retatrutide: The Triple Hormone Game-Changer [ 54:00 ] Muscle Preservation, Compounding & FDA Policy [ 59:00 ] Community, Advocacy & "On The Pen" [ 1:03:00 ] Closing Reflections *** Key Takeaways Alcohol may be an under-recognized root cause of metabolic resistance
PMID: 9849822
This combination provides strong appetite suppression from the GLP-1 component while the glucagon activity increases metabolic rate and promotes fat breakdown directly in the liver
Both medications reduce appetite through different mechanismsWegovy via GLP-1-mediated satiety signals, and lisdexamfetamine through central stimulant effects
Linus Pauling Institute Oregon State University Updated in November 2014 by: Barbara Delage, Ph.D
By crossing the blood-brain barrier, DSIP acts at the core of neural and systemic balance, enabling a multidimensional therapeutic impact ( 8, 9 )
